Ignite Creation Date:
2025-12-24 @ 3:29 PM
Ignite Modification Date:
2026-07-09 @ 7:38 AM
Study NCT ID:
NCT05652192
Status:
RECRUITING
Last Update Posted:
2022-12-15
First Post:
2022-11-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
SBRT Combined With Chemotherapy and Tislelizumab in Metastatic NPC
Sponsor:
Zhejiang Cancer Hospital
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Nasopharyngeal Carcinoma | View |
Keywords: